Chiesi Farmaceutici Overview
- Year Founded
-
1935
- Status
-
Private
- Employees
-
7,900
- Latest Deal Type
-
Debt
- Latest Deal Amount
-
$758M
Chiesi Farmaceutici General Information
Description
Manufacturer and Provider of biopharmaceutical research and therapeutic solutions headquartered in Parma, Italy. The company develops and produces pharmaceutical products specializing in respiratory health, rare diseases, and specialty care, operating multiple global production plants that manufacture life-saving medicines for neonatology, transplantation, and chronic respiratory conditions.
Contact Information
Website
www.chiesi.comCorporate Office
- Via Paradigna 131/A
- 43122 Parma
- Italy
Corporate Office
- Via Paradigna 131/A
- 43122 Parma
- Italy
Chiesi Farmaceutici Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Debt - General | 12-Apr-2023 | $758M | Completed | Generating Revenue |
Chiesi Farmaceutici Comparisons
Industry
Financing
Details
Chiesi Farmaceutici Competitors (32)
One of Chiesi Farmaceutici’s 32 competitors is Landsteiner Scientific, a Formerly PE-Backed company based in Toluca, Mexico.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Landsteiner Scientific | Formerly PE-Backed | Toluca, Mexico | ||||
| Novartis | Corporation | Basel, Switzerland | ||||
| Johnson&Johnson Innovative Medicine | Venture Capital-Backed | Raritan, NJ | ||||
| Recordati | Private Equity-Backed | Milan, Italy | ||||
| Astellas Pharma | Corporation | Tokyo, Japan |
Chiesi Farmaceutici Patents
Chiesi Farmaceutici Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026201946-A1 | Dry powder formulations for inhalation in form of soft pellets | Pending | 28-Mar-2025 | ||
| WO-2026162317-A1 | Treatment of progressive chronic interstitial lung disease with an anti-tg2 antibody | Pending | 28-Jan-2025 | ||
| WO-2026120023-A1 | Azaspiroheptane derivatives as ddr inhibitors | Pending | 04-Dec-2024 | ||
| WO-2026120024-A1 | Azaspiroheptane derivatives as ddr inhibitors | Pending | 04-Dec-2024 | ||
| WO-2026027399-A1 | Device for testing medicament inhalers | Pending | 29-Jul-2024 | G01M99/00 |
Chiesi Farmaceutici Signals
Chiesi Farmaceutici Investments & Acquisitions (23)
Chiesi Farmaceutici’s most recent deal was a Merger/Acquisition with KalVista Pharmaceuticals for . The deal was made on 11-Jun-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| KalVista Pharmaceuticals | 11-Jun-2026 | Merger/Acquisition | Drug Discovery | ||
| Chiesi Farmaceutici (Nerviano Manufacturing Plant in Nerviano, Italy) | 26-Mar-2025 | Corporate Asset Purchase | Buildings and Property | ||
| Santhera Pharmaceuticals (Idebenone Business) | 28-Jul-2023 | Merger/Acquisition | Biotechnology | ||
| Amryt Pharma | 12-Apr-2023 | Merger/Acquisition | Drug Discovery | ||
| Allinaire Therapeutic ( Worldwide Rights To a Portfolio of Therapeutic Monoclonal Antibodies) | 02-May-2022 | Corporate Asset Purchase | Drug Discovery |
Chiesi Farmaceutici Affiliates
Subsidiaries (10)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Unikeris | Manchester, United Kingdom | 2020 | |
| Amryt Pharma | London, United Kingdom | 2015 | |
| Chiesi Ventures | Boston, MA | 2014 | |
| Atopix | Oxon, United Kingdom | 2012 | |
| KalVista Pharmaceuticals | Framingham, MA | 2011 |
Chiesi Farmaceutici FAQs
-
When was Chiesi Farmaceutici founded?
Chiesi Farmaceutici was founded in 1935.
-
Where is Chiesi Farmaceutici headquartered?
Chiesi Farmaceutici is headquartered in Parma, Italy.
-
What is the size of Chiesi Farmaceutici?
Chiesi Farmaceutici has 7,900 total employees.
-
What industry is Chiesi Farmaceutici in?
Chiesi Farmaceutici’s primary industry is Pharmaceuticals.
-
Is Chiesi Farmaceutici a private or public company?
Chiesi Farmaceutici is a Private company.
-
What is Chiesi Farmaceutici’s current revenue?
The current revenue for Chiesi Farmaceutici is .
-
How much funding has Chiesi Farmaceutici raised over time?
Chiesi Farmaceutici has raised $758M.
-
Who are Chiesi Farmaceutici’s competitors?
Landsteiner Scientific, Novartis, Johnson&Johnson Innovative Medicine, Recordati, and Astellas Pharma are some of the 32 competitors of Chiesi Farmaceutici.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process